Trial intelligence / Profile preview

Timing of Travoprost/Timolol Fixed Combination in Glaucoma

NCT00331240Phase 3Completed

Sponsor
Aristotle University of Thessaloniki
Start
Mar 2006
Primary completion
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of travoprost + timolol in primary open-angle glaucoma (POAG), exfoliation syndrome (XFS), sponsored by Aristotle University of Thessaloniki. Started Mar 2006; status: completed.

02

Drugs

travoprost + timolol
03

Conditions

primary open-angle glaucoma (POAG)exfoliation syndrome (XFS)

Beyond the preview

Go deeper on NCT00331240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00331240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call